Medinotec Inc.
MDNC
$5.00
$0.000.00%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 45.24% | 56.80% | 71.25% | 82.18% | 158.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 45.24% | 56.80% | 71.25% | 82.18% | 158.20% |
| Cost of Revenue | 7.82% | 26.36% | 54.66% | 66.23% | 212.66% |
| Gross Profit | 93.29% | 94.41% | 90.30% | 99.02% | 110.99% |
| SG&A Expenses | 77.17% | 44.07% | 0.32% | -14.32% | 41.54% |
| Depreciation & Amortization | -52.56% | -32.81% | -8.65% | 15.49% | 126.68% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.92% | 33.89% | 35.83% | 34.72% | 133.52% |
| Operating Income | 124.41% | 172.37% | 286.03% | 431.39% | 375.40% |
| Income Before Tax | 153.63% | 750.48% | 5,229.88% | 1,292.00% | 351.39% |
| Income Tax Expenses | 82.50% | 140.04% | 217.05% | 473.41% | 828.21% |
| Earnings from Continuing Operations | 199.82% | 10,364.38% | 743.32% | 633.58% | 237.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 199.82% | 10,364.38% | 743.32% | 633.58% | 237.71% |
| EBIT | 124.41% | 172.37% | 286.03% | 431.39% | 375.40% |
| EBITDA | 110.59% | 154.82% | 253.62% | 374.28% | 318.60% |
| EPS Basic | 171.51% | 9,831.58% | 808.10% | 671.52% | 247.08% |
| Normalized Basic EPS | 116.22% | 203.31% | 350.58% | 556.03% | 1,175.86% |
| EPS Diluted | 171.51% | 9,831.58% | 808.10% | 671.52% | 247.08% |
| Normalized Diluted EPS | 116.22% | 203.31% | 350.58% | 556.03% | 1,175.86% |
| Average Basic Shares Outstanding | 8.90% | -2.15% | 9.27% | 9.27% | -4.22% |
| Average Diluted Shares Outstanding | 8.90% | -2.15% | 9.27% | 9.27% | -4.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |